The purpose of the study was to develop a Doppler modality for effective assessment of the fetoplacental circulation. Calculations based upon a theoretical model were employed to predict downstream pulsatility values in the fetoplacental circulation. The clinical study included 83 pregnancies between 32 and 36 weeks of gestation. Sixty-nine women were recruited from our low-risk clinic and had uncomplicated pregnancies. Fourteen patients had complications suspected to be associated with placental pathology. All 83 patients demonstrated UA Doppler indices within the normal limits for the gestational age. The study included intraplacental and UA Doppler waveform analyses. The ratios between intraplacental and UA PI values (at the cord insertion to the placenta) were calculated. Nineteen patients with intraplacental to UA (placental cord insertion) PI ratios > 1 (abnormal) had adverse pregnancy outcome. The study demonstrates the importance of detailed scanning of the intraplacental pulsatile waveforms and the importance of using the ratio between the intraplacental and UA Doppler indices as an additional method for evaluation of the fetoplacental circulation. The method might be proven more effective mainly in the early stages of placental disease when a relatively small number of the placental terminal arterioles are affected with a negligible effect on the UA Doppler indices, and also in the evaluation of the large placenta. A fetal growth classification based on detailed intraplacental velocimetry and cord to intraplacental flow gradient is proposed.

Keywords:
Placenta, Intraplacental Doppler waveforms, Placental disease, Fetoplacental circulation
This content is only available via PDF.
© 1997 S. Karger AG, Basel
1997
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.